Oncolytics Biotech Correlations
ONCY Stock | USD 1.19 0.05 4.03% |
The current 90-days correlation between Oncolytics Biotech and DiaMedica Therapeutics is -0.04 (i.e., Good diversification). The correlation of Oncolytics Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Oncolytics Biotech Correlation With Market
Significant diversification
The correlation between Oncolytics Biotech and DJI is 0.03 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Oncolytics Biotech and DJI in the same portfolio, assuming nothing else is changed.
Oncolytics | Build AI portfolio with Oncolytics Stock |
Moving together with Oncolytics Stock
0.64 | JNJ | Johnson Johnson | PairCorr |
0.62 | MRK | Merck Company Earnings Call This Week | PairCorr |
0.67 | PFE | Pfizer Inc | PairCorr |
0.74 | KMDA | Kamada | PairCorr |
0.78 | NKTR | Nektar Therapeutics | PairCorr |
0.71 | FNMFO | Federal National Mortgage Earnings Call This Week | PairCorr |
0.73 | SHG | Shinhan Financial Earnings Call This Week | PairCorr |
0.81 | WF | Woori Financial Group Earnings Call Today | PairCorr |
0.92 | BAC-PL | Bank of America | PairCorr |
0.85 | WFC-PL | Wells Fargo | PairCorr |
0.78 | INTC | Intel Earnings Call Tomorrow | PairCorr |
0.82 | CVX | Chevron Corp | PairCorr |
Moving against Oncolytics Stock
0.66 | BCH | Banco De Chile Earnings Call This Week | PairCorr |
0.32 | FATE | Fate Therapeutics Earnings Call This Week | PairCorr |
0.73 | PG | Procter Gamble Earnings Call This Week | PairCorr |
0.59 | TRV | The Travelers Companies | PairCorr |
0.43 | KO | Coca Cola | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Oncolytics Stock performing well and Oncolytics Biotech Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Oncolytics Biotech's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
DMAC | 3.31 | 0.37 | 0.09 | 0.59 | 3.59 | 8.61 | 23.31 | |||
SCPH | 3.52 | 0.99 | 0.31 | 0.82 | 2.69 | 9.32 | 35.11 | |||
MCRB | 5.27 | 0.47 | 0.13 | 0.35 | 5.09 | 13.48 | 35.28 | |||
ATYR | 3.48 | 0.83 | 0.18 | 1.54 | 3.69 | 7.78 | 19.68 | |||
IOVA | 5.15 | 0.00 | 0.03 | 0.17 | 9.37 | 12.43 | 50.12 | |||
XERS | 2.45 | 0.19 | 0.08 | 0.33 | 2.71 | 5.44 | 23.10 | |||
VTVT | 3.25 | (0.12) | 0.00 | (0.31) | 0.00 | 6.32 | 19.80 | |||
TRAW | 4.54 | (0.39) | 0.00 | (0.06) | 0.00 | 11.49 | 45.64 | |||
CYCC | 17.34 | 3.87 | 0.16 | (0.54) | 14.53 | 21.64 | 306.00 |
Oncolytics Biotech Corporate Management
Amy Levin | Vice Operations | Profile | |
FCA FCA | Consultant | Profile | |
Christophe Degois | Vice Development | Profile | |
Jon Patton | Director Communication | Profile | |
FACP FACP | Consultant | Profile |